| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |